Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Treatment of high blood pressure in the young. Semin Nephrol 1989 Sep;9(3):296-303

Date

09/01/1989

Pubmed ID

2675247

Scopus ID

2-s2.0-0024460234 (requires institutional sign-in at Scopus site)   2 Citations

Abstract

Children with high normal or high BP should also be evaluated for other cardiovascular risk factors, and interventions should address overall cardiovascular risk. Nonpharmacologic interventions include weight reduction when appropriate, avoidance of dietary salt excess, and dynamic exercise. Drug treatment should be required in a minority of children with hypertension. There are concerns about the longterm effects of drug therapy on lipid and carbohydrate metabolism and on physical and cognitive growth and development. Beta adrenergic antagonists and diuretics are usually the first line drugs to be added to the nonpharmacologic therapeutic strategies for BP control in children. After a sufficient period of BP control, a stepped-down approach and discontinuation of drug therapy should be considered.

Author List

Kotchen JM, Holley J, Kotchen TA



MESH terms used to index this publication - Major topics in bold

Antihypertensive Agents
Blood Pressure
Child
Humans
Hypertension